https://news.bloomberglaw.com/ip-law/lantheus-sued-by-novartis-for-patent-infringement-on-lutathera
Lantheus Sued by Novartis for Patent Infringement on Lutathera
Lantheus was sued by Novartis entities for patent infringement in response to the company’s filing of a Abbreviated New Drug Application for a generic version of lutathera.
- Company believes it is the “first applicant” to have filed a substantially complete ANDA containing a Paragraph IV certification under the provisions of the Hatch-Waxman Act
- Company believes it is eligible for 180 days of generic marketing exclusivity in the US
- Novartis has filed a lawsuit for patent infringement in the District Court for the District of Delaware
Ann: Telix 2023 Full Year Results and Investor Webcast/Call, page-5
-
- There are more pages in this discussion • 126 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$22.41 |
Change
0.210(0.95%) |
Mkt cap ! $7.500B | |||
| Open | High | Low | Value | Volume |
| $22.00 | $22.45 | $21.83 | $18.92M | 849.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2587 | $22.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $22.43 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 05/11/2024 (20 minute delay) ? |
| TLX (ASX) Chart |